DIP Episode 162 - ABP Peds Boards Series 1 (Metabolic Diseases)

Source / episode info

• Episode: 162
• Title: Divine Intervention Episode 162 – ABP Peds Boards Series 1 (Metabolic Diseases)
• Published: 2019-09-28
• Source: Episode page

One-liner

This episode provides a comprehensive review of pediatric metabolic disorders, emphasizing unique diagnostic patterns in aminoacidopathies (PKU, Homocystinuria, Tyrosinemia Type I) and differentiating the various urea cycle defects based on specific metabolite levels.

High-yield summary

• Autosomal Recessive Inheritance: Most IE Ms are inherited in an autosomal recessive fashion; exceptions include X-linked recessive disorders (Halo M mnemonic).
• PKU Pathophysiology: Deficiency of phenylalanine hydroxylase (PAH) leads to accumulation of phenylalanine and deficiency of tyrosine. Tyrosine becomes an essential amino acid, requiring dietary supplementation.
• Homocystinuria Differentiation: The specific pattern of elevated homocysteine and methionine helps differentiate the underlying enzyme defect (e.g., low methionine suggests CBS deficiency; high homocysteine/low methionine suggests B12 deficiency).
• Urea Cycle Defects (UC Ds): Diagnosis is based on analyzing the unique pattern of metabolites (Ammonia, Citrulline, Argininosuccinic Acid) to pinpoint the deficient enzyme.
• Tyrosinemia Type I: Classic triad includes liver failure/hepatocellular carcinoma, Fanconi syndrome presentation (hypophosphatemia, aminoaciduria), and a characteristic "cabbage" or "butter" urine odor due to accumulated succinylacetone.
• LPI Syndrome: This disorder presents after weaning from breastfeeding and involves the inability to reabsorb ornithine, lysine, and arginine in the kidney/intestine, leading to uremic symptoms.

Learning objectives

• Differentiate between various aminoacidopathies (PKU, Homocystinuria) based on unique metabolic profiles and clinical signs.
• Analyze laboratory values to diagnose the specific enzyme defect within the urea cycle pathway.
• Recognize the classic presentation triad of Tyrosinemia Type I: liver failure, Fanconi syndrome features, and characteristic urine odor.
• Understand the mechanism and management principles for aminoacidopathies (e.g., dietary restriction, cofactor supplementation).
• Identify the key differentiating metabolic markers among various IE Ms to improve diagnostic accuracy on board exams.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

Urea Cycle Defects: OTC vs CPS1 Deficiency

Urea Cycle Defects: Type I vs Type II Citrullinemia

Management pearls

• PKU Management: Dietary restriction of phenylalanine is paramount. Supplementation with L-dopa is necessary because tyrosine hydroxylase requires BH4, which is deficient.
• Homocystinuria Treatment: Supplementation with Vitamin B6 (pyridoxal phosphate), Vitamin B12 (cobalamin), and folic acid (or methyl donors) depending on the underlying enzyme defect.
• Tyrosinemia Type I Management: Dietary restriction of tyrosine and administration of Nitisinone to inhibit an upstream enzyme, thereby preventing succinylacetone buildup.
• UCD Management: Initial management involves reducing protein intake and providing high carbohydrate loads (glucose) to suppress ammonia production; specific treatments involve cofactor supplementation or substrate analogs (e.g., arglumine for NAGS deficiency).

Don't miss

Integration & clinical reasoning

• Metabolic Crisis Management (General): For any acute IEM crisis, immediate management involves NPO status, IV glucose administration to suppress protein catabolism and ammonia production, and potentially dialysis for severe hyperammonemia.
• Mitochondrial Dysfunction: Disorders like Leigh syndrome or those involving mitochondrial failure often present with lactic acidosis and neurological decline; the detection of "ragged red fibers" on muscle biopsy is a classic finding.
• Liver Failure Connection: Many IE Ms (e.g., Tyrosinemia Type I, UC Ds) cause secondary liver dysfunction due to the accumulation of toxic metabolites or impaired detoxification pathways.

OMM / COMLEX integration

• Standard emergency management protocols take priority in acute crises (e.g., hyperammonemia crisis requires immediate glucose administration and potentially dialysis). OMT is adjunctive only after stabilization.
• The concept of toxic metabolite accumulation (succinylacetone, high ammonia) relates to systemic metabolic stress, which can be managed by optimizing nutritional support and reducing catabolic load.

Concept connections / cross-references

• For general metabolic crisis management and aminoaciduria patterns: [Episode 160] (If discussing a related topic like organic acidemias).
• For detailed review of mitochondrial disorders and muscle biopsy findings: [Episode 175].
• For understanding the role of folate/B12 in one-carbon metabolism: [Episode 188].

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• Pattern: Child with intellectual disability, ectopia lentis, and elevated homocysteine -> Homocystinuria. This points to impaired methionine metabolism.
• Pattern: Early cirrhosis in a child + hypophosphatemia/aminoaciduria + urine smelling like cabbage -> Tyrosinemia Type I. The combination of liver failure and renal tubular damage is key.
• Pattern: Elevated ammonia with high citrulline, low argininosuccinic acid -> OTC Deficiency. This specific pattern helps differentiate it from other UC Ds.

Test yourself

Common mistakes to avoid

Common traps